Fingolimod Completed Phase 4 Trials for Relapsing Remitting Multiple Sclerosis (RRMS) Basic Science

IndicationsStatusPurposePhase
CompletedBasic Science4
clinicaltrials.gov IdentifierTitleDrugs
NCT01310166Biomarker Study After Initiation of Treatment With Fingolimod (FTY720) in Patients With Relapsing-remitting Multiple Sclerosis